Drag a card by its title · ⚙ to size, swap or remove

The company

NeOnc Technologies Holdings, Inc.

NTHI · Nasdaq

Health CareBiotechnologyNot moving yet

NTHI stood above a rising 150-day average in 14 of the last 47 weekly readings, and has been out of that trend for the last 32 weeks. It is 41.0% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 32
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $2.8M
Insider sales, 12 months: $34K
Officials’ trades on record: 0
Institutions holding: 22 (-4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 14 of 47 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months29

Sale orders, 12 months1

Buyers · sellers5 · 1

Who	Did	Shares	Traded
Amir F. HeshmatpourCEO, President	bought	35,000at $3.30	15 Sep 2026filed 15 Sep 2026
Keithly GarnettCFO	sold	5,000at $3.36	15 Sep 2026filed 18 Sep 2026
Keithly GarnettCFO	bought	257at $3.89	14 Sep 2026filed 15 Sep 2026
Thomas C. ChenCEO	bought	5,242at $3.82	14 Sep 2026filed 15 Sep 2026
Amir F. HeshmatpourCEO, President	bought	15,000at $3.96	14 Sep 2026filed 15 Sep 2026
Amir F. HeshmatpourCEO, President	bought	37,000at $3.67	11 Sep 2026filed 14 Sep 2026
Thomas C. ChenCEO	bought	5,556at $3.60	11 Sep 2026filed 15 Sep 2026
Amir F. HeshmatpourCEO, President	bought	9,000at $5.54	18 Aug 2026filed 18 Aug 2026
Thomas C. ChenCEO	bought	12,757at $5.49	18 Aug 2026filed 20 Aug 2026
Amir F. HeshmatpourCEO, President	bought	3,000at $4.37	17 Aug 2026filed 17 Aug 2026
Thomas C. ChenCEO	bought	2,472at $4.04	17 Aug 2026filed 18 Aug 2026
Thomas C. ChenChief Scientific Officer	bought	2,472at $4.04	17 Aug 2026filed 20 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders22-4 on the quarter

New · exited3 · 7

Reported value$14.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Cinctive Capital Management LPadded · filed 14 Aug 2026	1,607,464$7.3M	+181,938+12.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	504,171$2.3M	+288,471+133.7%
BANK OF AMERICA CORPreduced · filed 14 Aug 2026	224,412$1.0M	-10,984−4.7%
Westmount Partners, LLCadded · filed 7 Jul 2026	197,178$893K	+153,858+355.2%
BlackRock, Inc.added · filed 7 Aug 2026	179,850$815K	+24,012+15.4%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	166,120$753K	+39,267+31.0%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026	91,480$414K	+35,464+63.3%
STATE STREET CORPunchanged · filed 7 Aug 2026	43,170$196K	00.0%
NORTHERN TRUST CORPadded · filed 13 Aug 2026	35,871$162K	+12,600+54.1%
Global Retirement Partners, LLCnew · filed 6 Aug 2026	27,790$126K	+27,790